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With the success of antiretroviral therapy (ART) 
extending the life of people living with HIV/AIDS 
(PLWHA), there has emerged an aging HIV population 
and the long term consequences associated with ART 
toxicity. These consequences primarily affect metabolic 
processes often resulting in conditions similar to that of 
metabolic syndrome.
1,2
 For example, protease inhibitors 
have been shown to increase circulating blood lipids (i.e. 
triglycerides, cholesterol, etc.) and cause a pattern of 
abnormal fat deposition known as lipodystrophy - 
ABSTRACT 
 
Background: The purpose of this investigation was to test the feasibility of a home-based moderate-intensity 
physical activity (MPA) program for people living with HIV/AIDS (PLWHA) currently taking antiretroviral therapy 
(ART).  
Methods: 68 participants recruited for a 9-month home-based PA intervention aimed to reduce risk factors of 
cardiovascular disease for PLWHA taking ART. All participants received an educational weight loss workbook and a 
pedometer for self-monitoring of physical activity. The intervention group received elastic Therabands® for strength 
training in addition to telephone based behavioural coaching. Clinical assessments were conducted at baseline and 
each follow-up which also included psychometric questionnaires and PA levels via the SenseWear® armband 
accelerometer.  
Results: Of the 57 completing the study, 29 of those were in the intervention group and 28 were in the standard care 
group. Results show that the home-based PA intervention was not successful in increasing the total amount of MPA 
for PLWHA. However there was a trend (p=0.08) of decreasing sedentary time. In a secondary analysis those who 
increased PA by >10% observed decreases in waist circumference and improved functioning at 18 weeks. None of the 
changes observed were significant after controlling for all potential confounders.   
Conclusions: A home-based exercise approach with telephone-based coaching may not be a feasible method for 
increasing MPA among PLWHA. Slight decreases in sedentary time indicate some positive changes in activity habits. 
A possible strategy to improve studies similar to this is to incorporate a group based social interaction each week 
similar to that of a support group. 
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resulting in central fat accumulation. Other classes of 
antiretrovirals are known to cause gastrointestinal and 
metabolic consequences. Evidence has shown that the 
risk for cardiovascular and diabetes related complications 





Physical activity has been widely accepted as a way to 
reduce the incidence and risk of cardiovascular disease 
and diabetes in the general population as well as 
PLWHA.
4-6
 Physical activity is especially important to 
PLWHA because the side effects associated with ART 
can have a synergistic effect on lifestyle choices such as 
sedentary living, unhealthy diets, and other determinants 
of chronic disease. Routine physical activity could be 
successful in reducing some of the side effects of HIV 
infection/treatment and help self-manage the disease 
while improving quality of life. 
 
Routine physical activity has proven benefits in general 
and clinical populations.
4,7-13
 Many of the physiological 
benefits of activity are a direct result of metabolic 
improvements (i.e. improved lipid panel, reduced waist 
circumference and body fat, etc.) with long-term 
improvements in cardiorespiratory health. Randomized 
controlled trials of physical activity interventions have 
shown decreases in body weight and visceral fat 
accumulation, increased HDL cholesterol, decreased 
triglycerides, and improved insulin sensitivity.
9,14,15
 These 
studies are of various lengths with some lasting as little as 
6-8 weeks and others showing benefits from year-long 
interventions. What is unclear, however, is whether 
PLWHA on ART intervention will benefit similarly from 
a physical activity intervention. Because the rate of HIV 
infection continues to increase in low-income 
populations, it is important that cost-effective 
interventions aimed at increasing physical activity are 
identified and implemented. The increased number of 
barriers to physical activity among many PLWHA 
requires the development of effective interventions that 
can be provided to large numbers at a low cost. 
 
A number of studies demonstrate the effectiveness of 
community-based physical activity interventions.
8,12,16
 
These interventions range from group-based classroom 
activities that emphasize behavior modification and 
education all the way to simple home-based approaches 
that incorporate weekly or bi-weekly telephone calls from 
a trained health educator. These strategies have been 
shown to be effective in a range of populations. Similar 
home-based activity programs have targeted healthy 
populations as well as a variety of clinical populations 
such as those with heart failure, cancer, sporadic 
inclusion body myositis, chronic obstructive pulmonary 
disorder, and outcomes associated with various 
inflammatory responses.
12,13,17
 To date, there have been 
no published investigations that incorporate a home-
based exercise approach for PLWHA. 
 
 
There is a growing body of evidence suggesting plwha 
can achieve similar benefits in routine physical activity 
commonly observed in the general population.
7,11,18-20
 The 
use of a home-based physical activity intervention in 
other clinical populations has successfully increased the 
amount of daily physical activity accumulated when 
compared to a control group.
12,21,22
 These programs 
incorporated moderate-intensity physical activity, which 
has been shown to be safe for clinical populations with 
functional limitations.
23,24
 Similar physical activity 
interventions are needed that can improve self-
management of metabolic conditions among PLWHA 
taking art. The purpose of this study was to evaluate the 
feasibility of a home-based physical activity intervention 
aimed to increase moderate intensity physical activity and 





Study participants were recruited from local physicians, 
clinics, and HIV/AIDS support groups in the greater 
Columbia and Charleston, SC areas. There were 68 
participants enrolled in the study and randomized into 
one of two groups.  For a complete list of the inclusion 
and exclusion criteria see Table 1. Out of the initial 68 
participants who were randomized, 62 completed the 18 
week data collection period, and 57 completed the full 36 
week study. There were six outliers identified at baseline 
leaving a total of 62 participants for the final intent-to-
treat data analysis. Outliers were determined according to 
baseline moderate-intensity physical activity values that 
were 3 standard deviations higher or lower than the total 
average. Figure 1 provides a schematic of participant 
involvement through randomization and 36 week follow-
up. The detailed description of the study methodologies 
and participant recruitment for this study has been 
published previously.
25




After completion of baseline assessments all participants 
were randomized into one of two groups: 1) Home-based 
physical activity intervention or 2) standard care. Both 
groups received an evidence-based book on healthful 
eating and regular physical activity and a pedometer.
26
 
Those randomized into the intervention group received a 
one-on-one physical activity training session from a 
trained interventionist to further explain participant 
expectations. The training session provided an overview 
of what constitutes physical activity, benefits of physical 
activity, different types of physical activity, current 
physical activity recommendations, tips for starting a 
physical activity program and proper use of the activity 
log. Additionally, the session included a demonstration 
for use of the elastic Thera-bands® for strength training.  
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Intervention  
 
Two interventionists were trained by a clinical 
psychologist with expertise in behavioral interventions to 
implement the Active Choices program (developed at 
Stanford University).  Active Choices is a home-based 
physical activity program that uses theoretically-based 
strategies to help participants make lifestyle changes and 
is based on both social cognitive theory and the 
transtheoretical model.
27
  The intervention began with a 
60-minute individual face-to-face session in which 
rapport was established; the program and expectations 
were described; a physical activity and diet history was 
taken; explanation of realistic, specific, and measurable 
short-term and long-term goals was addressed; safety 
information was provided; instructions for wearing a 
pedometer was given; self-monitoring tools (pedometer 
and log) were distributed; and a schedule for follow-up 
telephone calls was set. In addition to the education 
session the health educator worked with each participant 
to help them establish reasonable short term goals that 
would eventually lead up to a common long term goal 
among the participants (> 150 minutes of routine 





Figure 1: CONSORT flow diagram. 
Non-exercise Standard Care Group 
 
Participants in the standard care group received the same 
educational material and weight loss manual as those 
randomized to the physical activity group.  Physical 
activity habits were monitored throughout the study for 
participants randomized to the standard care group in the 
same manner as for the intervention group using the 
SenseWear
® 
armband.  One potential problem in this 
group was the possibility of participants losing interest in 
the study because they were assigned to a “control” 
group.  We have been successful in reducing standard 
care group dropout in previous studies by maintaining 
telephone contact with standard care group participants.  
In this study, we initiated contact with the standard care 
group participants by telephone every two weeks to 
update health status, maintain current contact 
information, and emphasized the importance of their 




The primary outcome of interest for this investigation 
was moderate-intensity physical activity as measured by 
the Sensewear® armband. This measurement was used as 
an index of program adherence and total accumulation of 
daily physical activity. Using tri-accelerometry 
technology augmented by 2 heat sensors (a thermistor-
based skin surface sensor and a proprietary heat flux 
sensor), and a galvanic skin response sensor, the device is 
able to accurately measure and record total energy 
expenditure, and also measures activity intensity. The 4 
internal sensors turn on the monitor when detecting skin 
contact and measures total time the armband was worn, 
daily energy expenditure, step count, sleep efficiency, 
and the intensity, duration, and frequency of physical 
activity bouts.  
 
All arm band data were analyzed by computer-based 
software using demographic information (gender, age, 
height, and weight at prior assessment) and proprietary 
algorithms.  Validity of armband energy expenditure 
estimates has been reported in several conditions 
including resting, exercise (i.e. treadmill and cycle 
ergometer), and free-living conditions (i.e. physical 
activity and exercise).
28,29
 St-Onge et al. found that when 
comparing the armband to doubly labeled water daily 
energy expenditure had an interclass correlation of 0.81 
(P < 0.01) between the two methods.
30
 When comparing 
the armband to the Intelligent Device for Estimating 
Energy Expenditure and Activity (IDEEA) Welk et al. 
showed comparable results between the armband and 
IDEEA when estimating energy expenditure and PA.
29
 
Participants were required to wear the armband for a 
minimum of 10 hours on 4 separate days for the armband 
data to be considered valid. Secondary outcomes included 
physiological and psychological variables, such as 
cardiorespiratory fitness (VO2), body composition, full 
blood lipid panel, serum C - reactive protein (CRP), 
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interleukin-6 (IL-6), depression, anxiety, stress, and 




Graded exercise stress test: Following a medical 
examination including evaluation of family and personal 
medical history, resting blood pressure, and resting ECG 
evaluation, each participant completed a graded exercise 
treadmill test (GXT). The GXT was used to screen for 
abnormal physiological responses to exercise, including 
blood pressure and ECG responses, and for determining 
the participant’s current level of cardiorespiratory fitness. 
The test was terminated either at volitional exhaustion or 
at observation of abnormal responses that are 
contraindications for exercise. This test has been found to 





Body mass index and visceral fat: Anthropomorphic 
measurements were made using standard laboratory 
equipment. Height and weight were used to determine 
body mass index (BMI, weight in kg/height in meters
2
) as 
an index of total body fat. Waist circumference (WC) was 
measured as an index of visceral fat. Waist circumference 
is only an indirect measure of visceral fat, but budget 
constraints preclude more direct measurement of visceral 
fat.
32
   
 
Self-report questionnaires  
 
Perceived stress scale (PSS): The 10-item PSS assesses 
the degree to which an individual finds life events 
unpredictable, uncontrollable, or overwhelming.
33
 
Internal consistency has been demonstrated by a 
Cronbach’s alpha of 0.78.
33
 Validity of the PSS is 
supported by significant correlations with greater help-
seeking, poorer health, more health service utilization, 




MOS 36-item short-form health survey (SF-36): The SF-
36 is a widely used and validated self-report measure of 
health-related quality of life.
34
 It consists of eight health 
concepts including physical function, social function, 
pain, mental health, energy/fatigue, general health 
perceptions, role limitations due to physical problems, 
and role limitations due to emotional problems. The SF-
36 can be divided into the two parts: the Mental 
Composite Score (MCS) and the Physical Composite 
Score (PCS). The internal consistency reliability 





Centers for epidemiologic studies-depression (CES-D):  
The 20-item CES-D is a widely used and validated self-
report measure of depressive symptoms.
36
 Components of 
the CES-D include depressed mood, feelings of guilt and 
worthlessness, feelings of hopelessness and helplessness, 
psychomotor retardation, loss of appetite, and sleep 
disturbance. The CES-D has a high internal consistency 





Blood Sampling and Analyses 
 
Blood draws were performed following an 8 hour fast at 
baseline, 18 weeks, and 36 weeks.  Participants were 
asked to refrain from taking aspirin and other anti-
inflammatory medications for 48 hours prior to the blood 
draw.  Twenty milliliters of whole venous blood was 
drawn into standard vacutainer tubes by trained 
personnel.  Standard separation procedures were used for 
collection of serum and plasma.  Samples were stored at -
80º C until ready for analysis. The blood components of 
interest were measured in duplicate by LabCorp
®
 clinical 
trials division. All samples were analyzed by a LabCorp 
professional at a central location that undergoes rigorous 
quality assurance testing to deliver high accuracy and 
reliability in the results.  
 
Statistical analyses 
We conducted an intent-to-treat analysis to test the 
feasibility of this home-based study. Missing 
observations were imputed into the dataset by the last 
observation carried forward method. Outliers were 
identified as participants who accumulated more than 3 
standard deviations from the sample mean of moderate 
intensity physical activity at baseline and removed from 
the dataset. All analyses were performed using SPSS 
statistical software. Treatment effects were evaluated 
using a two way ANOVA by conducting a repeated 
measure general linear model controlling for age, gender, 
VO2, and baseline measures. Analyses were performed 
on all outcome variables and accelerometer data. In a 
secondary data analysis to determine changes in 
secondary outcomes participants were divided into one of 
two groups according to changes in physical activity. 
Those in group 1 increased their average minutes per day 
of moderate intensity physical activity by more than 10%, 
whereas group 2 included the participants who stayed 
within 10% or less of their daily physical activity average 
measured at baseline and the 18 week follow-up.  The 
same groups were then created according to changes in 
physical activity from baseline to 36 week follow-up. 
Differences within and between groups were conducted 
in a similar manner previously described but also 
controlled for group assignment (intervention or standard 
care). 
RESULTS 
At baseline there were no significant differences between 
intervention and the standard care group for any 
demographic, medical characteristics, or outcome 
variables. All participants were currently taking a 
combination antiretroviral regimen and none reported 
changes in medications throughout the study duration.  
The majority of participants (54%) were females and 
African-American (82%), with a self-reported income 
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less than $30,000 (69%). The average age was 47.1±9.4 
years. Table 2 shows the baseline values of each outcome 
variable. The mean duration of moderate intensity 
activity for all participants was 91.6±77.8 minutes per 
day and average sedentary time was 881.9±403.5 minutes 
per day. No significant differences were found within or 
between groups at the 18 week or 36 week time points for 
any of the measured variables as seen in Table 2.  
 
Tables 3.1 and 3.2 show the results of the secondary data 
analysis in which participants were separated into groups 
according to changes in physical activity. Those who 
increased their activity levels by 10% or more showed a 
decreasing trend in waist circumference that barely 
reached significance (p = 0.05) at the 18 week time point, 
but not 36 weeks. Systolic blood pressure also 
 significantly decreased (p = 0.023) for those who 
increased their daily physical activity at 18 weeks, but no 
difference was observed at 36 weeks. As expected there 
were also significant changes in moderate intensity 
physical activity and sedentary time for both groups at 
each time point. No significant differences were observed 
among the other physiological variables. No significant 
differences were observed in the psychological variables.  
 
A decreasing trend was observed in role functioning and 
physical health of the intervention group at 18 weeks, but 
this did not continue at 36 weeks. A reduction in pain was 
seen at 36 weeks in the intervention group; role 
limitations due to emotional health at 18 weeks also 
exhibited a downward trend. After controlling for 
potential confounders, none of the trends were 
statistically significant. 
 
Table 1: Inclusion and exclusion criteria. 
Inclusion Criteria  
 Age 18 years and older  
 Medical diagnosis of HIV-1 positive serostatus 
 Sedentary lifestyle: not actively exercising ≥ 3 d·wk-1 for 20 min per session 
 Stable, DHHS-approved ART regimen for previous 3 months, with HIV viral load below 75 copies/mL 
 Capable of performing the required exercise regimen 
 Have daily access to a telephone for approximately 10 months  
 Capacity and willingness to provide informed consent and accept randomized group assignment 
Exclusion Criteria  Temporary Exclusion Criteria 
 Individuals who have a clinical history strongly 
suggestive of Type 1 diabetes.   
 History of serious arrhythmias, cardiomyopathy, 
congestive heart failure, stroke or transient ischemic 
cerebral attacks, peripheral vascular disease with 
intermittent claudication, myocardial infarction, or 
CABG. 
 Malignancies in the past 5 years, except therapeutically 
controlled skin cancer.   
 Plans to be away  > 4 weeks in the next 9 months 
 Score of 5 or greater on the DAST or MAST 
(signifying excessive use of drugs or alcohol). 
 Weight loss in excess of 10% body weight in previous 
12 weeks. 
 Chronic or recurrent respiratory, gastrointestinal, 
neuromuscular, neurological, or psychiatric conditions.  
 Inflammatory-related conditions such as collagen 
disorders.    
 Any other medical condition or disease that is life-
threatening or that can interfere with or be aggravated 
by exercise. 
 Total cholesterol 240 mg/dl with LDL-C 160 
mg/dl or TG levels 300 mg/dl. Note: Individuals 
on cholesterol lowering medications but meeting 
blood lipid requirements are eligible. 
 Resting blood pressure >160 systolic and/or 90 
diastolic. Note: Individuals on blood pressure 
medications but meeting blood pressure criteria are 
eligible. 
 HbA1c 11%.  Individuals whose HbA1c exceeds 
this level will be recommended to seek treatment 
immediately.  Such individuals may be re-screened 
after three months to re-assess HbA1c eligibility. 
 Current opportunistic infection at the time of 
screening. 
 Participation in another intervention trial. 
 Other temporary intervening event, such as sick 
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Table 2: Results of measured outcomes. 
 Variable Baseline 18 weeks 36 weeks p value 
 Weight in pounds, Mean ± SD     
 Standard Care 190.68 ± 49.79 195.65 ± 53.86 195.74 ± 53.42 0.94 
 Intervention 192.36 ± 40.25 193.16 ± 41.02 196.01 ± 41.72 0.96 
 BMI (kg/m
2
), Mean ± SD     
 Standard Care 30.88 ± 8.39 31.11 ± 8.73 31.33 ± 9.22 0.99 
 Intervention 30.29 ± 4.85 30.28 ± 4.43 31.43 ± 5.50 0.97 
 Waist circumference, Mean ± SD     
 Standard Care 99.47 ± 18.70 100.63 ± 18.31 100.76 ± 18.77 0.97 
 Intervention 99.08 ± 12.43 96.31 ± 17.75 101.64 ± 14.28 0.55 
 Blood Pressure, Mean ± SD     
 Systolic (mmHg)     
 Standard Care 129 ± 15 125 ± 12 129 ± 19 0.66 
 Intervention 128 ± 15 124 ± 13 125 ± 14 0.58 
 Diastolic (mmHg)     
 Standard Care 82 ± 11 82 ± 10 83 ± 12 0.95 
 Intervention 82 ± 9 78 ± 8 82 ± 10 0.35 
 Fasting blood analysis, Mean ± SD  
 Cholesterol (mg/dL)     
 Standard Care 172.82 ± 33.58 174.29 ± 36.43 183.94 ± 31.35 0.59 
 Intervention 199.94 ± 61.09 199.90 ± 40.08 205.69 ± 39.49 0.94 
 Triglycerides (mg/dL)     
 Standard Care 116.18 ± 68.44 145.82 ± 122.64 138.63 ± 147.78 0.75 
 Intervention 179.94 ± 189.19 188.40 ± 123.30 168.23 ± 107.30 0.95 
 LDL (mg/dL)     
 Standard Care 100.71 ± 28.64 99.06 ± 31.21 106.60 ± 29.15 0.76 
 Intervention 116.07 ± 39.78 122.89 ± 39.76 122.17 ± 34.75 0.88 
 HDL (mg/dL)     
 Standard Care 48.76 ± 12.59 50.65 ± 13.36 51.81 ± 13.13 0.79 
 Intervention 44.50 ± 22.75 47.40 ± 19.84 48.69 ± 21.50 0.87 
 VLDL (mg/dL)     
 Standard Care 23.35 ± 13.65 24.88 ± 17.69 20.87 ± 12.28 0.75 
 Intervention 27.07 ± 12.46 32.56 ± 18.86 29.75 ± 16.85 0.72 
 Glucose (mg/dL)     
 Standard Care 116.41 ± 40.63 119.65 ± 89.02 100.75 ± 21.94 0.62 
 Intervention 116.31 ± 59.45 113.40 ± 63.47 85.52 ± 30.36 0.27 
 C-Reactive Protein (mg/L)     
 Standard Care 6.62 ± 6.89 5.00 ± 4.75 4.04 ± 4.36 0.39 
 Intervention 4.53 ± 5.10 4.27 ± 3.23 5.29 ± 5.17 0.86 
 Interleukin-6 (pg/mL)     
 Standard Care 4.77 ± 2.11 3.34 ± 2.45 4.30 ± 2.77 0.25 
 Intervention 3.00 ± 1.58 3.16 ± 2.10 11.86 ± 33.14 0.43 
 PA Outcomes (Average minutes per day)  
 MVPA     
 Standard Care 93.35 ± 92.51 89.59 ± 79.29 96.36 ± 80.33 0.96 
 Intervention 89.90 ± 63.14 83.16 ± 72.23 79.26 ± 64.15 0.88 
 Light PA     
 Standard Care 221.23 ± 126.89 203.36 ± 84.41 230.82 ± 114.30 0.71 
 Intervention 190.62 ± 71.32 181.74 ± 74.79 198.16 ± 93.20 0.82 
 Sedentary     
 Standard Care 838.32 ± 249.61 848.23 ± 231.70 808.05 ± 274.80 0.86 
 Intervention 925.48 ± 153.86 787.37 ± 232.04 816.26 ± 224.90 0.08 
 Steps (Average per day)     
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 Standard Care  5905.55 ± 2944.37 6179.47 ± 2865.38 6610.17 ± 3886.32 0.14 
 Intervention 5870.37 ± 2893.44 5285.38 ± 2483.99 5769.52 ± 3724.28 0.77 
 Sleep Metrics  (Average hours per day)    
 Total sleep time      
 Standard Care 4.41 ± 1.64 4.32 ± 2.07 4.36 ± 1.75 0.99 
 Intervention 4.99 ± 1.69 3.92 ± 2.29 4.43 ± 2.45 0.29 
 Sleep efficiency (%)     
 Standard Care 73.44 ± 10.72 73.96 ± 8.72 75.84 ± 8.61 0.64 
 Intervention 73.71± 13.30 72.75 ± 16.79 71.47 ± 12.49 0.87 
Table 3.1: Physical activity changes from baseline to 18 weeks. 
Variable Baseline 18 Weeks P value 
BMI (kg/m
2
), Mean ± SD 
   
Standard Care 30.92 ± 6.14 31.41 ± 6.15 0.12 
Intervention 32.26 ± 5.14 31.99 ± 5.50 0.23 
Waist circumference, Mean ± SD 
   
Standard Care 100.15 ± 15.23 99.35 ± 17.35 0.33 
Intervention 104.11 ± 13.53 102.89 ± 12.68 0.05 
Blood Pressure, Mean ± SD 
   
Systolic (mmHg) 
   
Standard Care 127 ± 16 124 ± 11 0.11 
Intervention 130 ± 16 124 ± 80 0.03 
Diastolic (mmHg) 
   
Standard Care 82 ± 4 80 ± 8 0.16 
Intervention 84 ± 9 80 ± 10 0.09 
Activity Monitor Outcomes, Mean ± SD 
   
Measured EE 
   
Standard Care 2280.87 ± 712.93 2094.54 ± 581.93 <0.001 
Intervention 2289.42 ± 500.32 2244.55 ± 556.19 0.35 
Steps 
   
Standard Care 6106.75 ± 4025.09 5236.41 ± 2684.68 0.004 
Intervention 5540.08 ± 2839.96 6331.07 ± 2890.79 0.03 
Sedentary Time 
   
Standard Care 855.05 ± 167.62 818.61 ± 200.87 0.04 
Intervention 912.58 ± 133.39 785.05 ± 188.57 0.008 
Light Activity 
   
Standard Care 180.81 ± 38.16 172.23 ± 44.47 0.25 
Intervention 202.75 ± 60.87 215.06 ± 75.71 0.28 
Moderate Activity 
   
Standard Care 82.16 ± 71.64 67.82 ± 54.37 0.001 
Intervention 59.00 ± 58.10 89.16 ± 64.77 <0.001 
Vigorous Activity 
   
Standard Care 5.27 ± 2.53 2.88 ± 1.39 0.06 
Intervention 4.25 ± 2.39 5.43 ± 4.38 0.12 
Sleep Hours 
   
Standard Care 4.38 ± 1.29 5.18 ± 1.53 0.17 
Intervention 4.78 ± 1.23 4.05 ± 1.88 0.04 
Fasting blood analysis, Mean ± SD 
   
Cholesterol (mg/dL) 
   
Standard Care 182.94 ± 30.29 180.10 ± 40.44 0.31 
Intervention 194.25 ± 35.83 191.65 ± 35.08 0.34 
Triglycerides (mg/dL) 
   
Standard Care 160.81 ± 93.83 142.39 ± 112.24 0.21 
Intervention 140.70 ± 67.66 158.26 ± 119.70 0.24 
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LDL (mg/dL) 
   
Standard Care 104.03 ± 36.36 103.13 ± 37.17 0.38 
Intervention 119.61 ± 38.54 111.13 ± 38.80 0.26 
HDL (mg/dL) 
   
Standard Care 46.19 ± 13.89 49.23 ± 14.39 0.19 
Intervention 46.48 ± 14.18 50.74 ± 14.05 0.09 
VLDL (mg/dL) 
   
Standard Care 28.58 ± 18.89 27.68 ± 17.71 0.35 
Intervention 28.26 ± 13.46 29.48 ± 17.12 0.13 
Glucose (mg/dL) 
   
Standard Care 110.19 ± 69.27 110.26 ± 68.55 0.49 
Intervention 109.09 ± 43.15 116.57 ± 93.59 0.28 
C-Reactive Protein (mg/L) 
   
Standard Care 5.77 ± 6.24 5.72 ± 5.79 0.46 
Intervention 4.85 ± 5.38 4.23 ± 3.07 0.17 
Interleukin-6 (pg/mL) 
   
Standard Care 4.30 ± 1.27 4.46 ± 1.33 0.46 
Intervention 4.20 ± 2.21 3.89 ± 2.08 0.16 
Questionnaires 
   
Perceived Stress 
   
Standard Care 14.84 ± 2.54 15.66 ± 3.16 0.72 
Intervention 16.59 ± 3.74 18.23 ± 4.25 0.16 
CESD 
   
Standard Care 15.15 ± 6.25 14.13 ± 6.25 0.49 
Intervention 11.85 ± 17.57 17.57 ± 4.98 0.06 
SF-36 (Quality of Life) 
   
Physical Functioning 
   
Standard Care 81.32 ± 5.63 78.55 ± 6.41 0.32 
Intervention 79.77 ± 3.20 65.31 ± 2.38 0.03 
Role Limitations (Physical Health) 
   
Standard Care 76.97 ± 5.19 32.89 ± 4.12 0.08 
Intervention 83.33 ± 5.57 34.38 ± 7.79 0.05 
Role Limitations (Emotional Health) 
   
Standard 79.82 ± 5.83 25.43 ± 5.82 0.001 
Intervention 79.17 ± 6.89 41.67 ± 7.84 0.005 
Energy/Fatigue 
   
Standard 64.52  ± 3.27 62.57 ± 3.59 0.92 
Intervention 62.29 ± 3.88 60.63 ± 4.04 0.86 
Mental Health 
   
Standard Care 72.21 ± 3.09 70.92 ± 3.57 0.65 
Intervention 70.92 ± 3.57 67.25 ± 3.92 0.07 
Social Function 
   
Standard Care 76.97 ± 3.93 73.31 ± 4.44 0.24 
Intervention 77.60 ± 4.05 66.67 ± 6.34 0.09 
Pain 
   
Standard Care 75.21 ± 3.87 74.14 ± 4.20 0.72 
Intervention 76.35 ± 4.47 65.31 ± 5.51 0.303 
General Health 
   
Standard Care 64.21 ± 3.66 67.31 ± 3.45 0.11 
Intervention 61.67 ± 4.94 60.21 ± 4.13 0.66 
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Table 3.2: Physical activity changes from baseline to 36 weeks. 
Variable Baseline 36 weeks p value 
BMI (kg/m
2
), Mean ± SD 
   
Standard Care 31.47 ± 6.08 32.16 ± 7.35 0.23 
Intervention 30.18 ± 5.23 30.11 ± 5.31 0.44 
Waist circumference, Mean ± SD 
   
Standard Care 101.49 ± 13.02 102.24 ± 15.15 0.17 
Intervention 99.30 ± 14.27 99.17 ± 15.48 0.47 
Blood Pressure, Mean ± SD 
   
Systolic (mmHg) 
   
Standard Care 127 ± 18.82 126 ± 17.43 0.27 
Intervention 130.00 ± 11.39 128.00 ± 20.49 0.38 
Diastolic (mmHg) 
   
Standard Care 83 ± 10.5 82 ± 10.17 0.16 
Intervention 83.00 ± 6.36 85.00 ± 11.37 0.27 
Activity Monitor Outcomes, Mean ± SD 
 
Measured EE 
   
Standard Care 2273.37 ± 639.32 2142.65 ± 475.44 0.02 
Intervention 2338.76 ± 543.88 2583.92 ± 547.50 0.004 
Steps 
   
Standard Care 5734.45 ± 3464.75 5498.74  ± 2643.26 0.14 
Intervention 6459.52 ± 2918.25 9214.95  ± 3915.20 0.02 
Sedentary Time 
   
Standard Care 945.68 ± 152.83 895.74 ± 246.84 0.02 
Intervention 890.00  ± 121.82 779.83 ± 145.64 0.035 
Light Activity 
   
Standard Care 185.59 ± 59.75 193.61 ± 73.17 0.13 
Intervention 207.33 ± 61.56 236.25 ± 86.83 0.07 
Moderate Activity 
   
Standard Care 72.76 ± 67.59 65.53 ± 48.5 0.004 
Intervention 74.33 ± 62.07 126.50 ± 79.31 0.001 
Vigorous Activity 
   
Standard Care 5.17 ± 2.94 2.6 ± 1.2 0.03 
Intervention 4.33 ± 68.55 4.50 ± 3.35 0.38 
Sleep Hours 
   
Standard Care 4.46 ± 1.54 4.15 ± 1.98 0.07 
Intervention 4.45 ± 1.03 4.58 ± 1.71 0.31 
Fasting blood analysis, Mean ± SD 
   
Cholesterol (mg/dL) 
   
Standard Care 184.42 ± 38.52 194.5 ± 57.58 0.42 
Intervention 203.27 ± 47.45 191.09 ± 40.24 0.19 
Triglycerides (mg/dL) 
   
Standard Care 132.69 ± 81.78 143.41 ± 139.77 0.18 
Intervention 240.27 ± 55.42 194.55 ± 178.79 0.15 
LDL (mg/dL) 
   
Standard Care 110.84 ± 40.95 115.5 ± 47.75 0.19 
Intervention 107.00 ± 41.35 102.11 ± 42.22 0.31 
HDL (mg/dL) 
   
Standard Care 46.96 ± 12.37 50.2 ± 12.16 0.21 
Intervention 45.55 ± 27.96 49.45 ± 23.85 0.16 
VLDL (mg/dL) 
   
Standard Care 26.62 ± 16.4 27.41 ± 12.64 0.39 
Intervention 25.56 ± 11.03 24.33 ± 21.86 0.35 
Glucose (mg/dL) 
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Standard Care 109.76 ± 64.75 97.73 ± 26.22 0.11 
Intervention 104.09 ± 32.57 92.00 ± 14.51 0.09 
C-Reactive Protein (mg/L) 
   
Standard Care 5.21 ± 5.22 5.03 ± 5.1 0.19 
Intervention 5.09 ± 6.04 2.95 ± 2.70 0.11 
Interleukin-6 (pg/mL) 
   
Standard Care 4.24 ± 2.25 7.25 ± 2.03 0.15 
Intervention 3.93 ± 1.65 3.25 ± 1.07 0.07 
Questionnaires 
   
Perceived Stress 
   
Standard Care 15.32 ± 1.08 15.24 ± 0.98 0.32 
Intervention 16.17 ± 1.86 17.58 ± 2.58 0.12 
CESD 
   
Standard Care 14.24 ± 1.65 12.96 ± 1.39 0.53 
Intervention 12.33 ± 3.35 18.50 ± 4.67 0.13 
SF-36 (Quality of Life) 
   
Physical Functioning 
   
Standard Care 78.37 ± 3.36 73.01 ± 3.89 0.08 
Intervention 90.52 ± 4.03 75.74 ± 8.71 0.08 
Role Limitations (Physical Health) 
   
Standard Care 76.02 ± 2.85 30.39 ± 4.66 0.45 
Intervention 91.67 ± 2.43 25.00 ± 4.75 0.03 
Role Limitations (Emotional Health) 
   
Standard 80.27 ± 7.34 35.33 ± 5.51 0.45 
Intervention 75.00 ± 3.96 30.56 ± 10.43 0.21 
Energy/Fatigue 
   
Standard 62.43 ± 2.94 61.60 ± 3.16 0.86 
Intervention 68.75 ± 3.75 64.58 ± 5.55 0.57 
Mental Health 
   
Standard Care 72.32 ± 2.70 74.82 ± 2.73 0.57 
Intervention 75.00 ± 3.45 71.67 ± 5.33 0.23 
Social Function 
   
Standard Care 76.96 ± 3.16 77.50 ± 3.94 0.23 
Intervention 80.21 ± 6.61 68.75 ± 7.77 0.43 
Pain 
   
Standard Care 73.25 ± 3.36 70.41 ± 3.76 0.19 
Intervention 85.63 ± 4.67 61.25 ± 8.16 0.001 
General Health 
   
Standard Care 62.61 ± 3.31 63.80 ± 2.92 0.49 
Intervention 65.83 ± 6.42 71.25 ± 5.51 0.23 
 
DISCUSSION 
The purpose of this investigation was to test the 
feasibility and short-term effectiveness of a 9-month 
home-based physical activity intervention to increase 
moderate-intensity physical activity and reduce cardio-
metabolic risk among PLWHA compared to standard 
care. We found that compared to standard care, a home-
based walking intervention was not effective for 
increasing daily physical activity levels among PLWHA 
who were not regularly active prior to the intervention. 
Activity levels were measured at 18 and 36 weeks post 
randomization and neither time point showed a 
significant change in daily physical activity. Due to the 
lack of increases in physical activity, it was not surprising 
to observe no changes in cardio-metabolic risk factors. 
These findings are conflicting with similar home-based 
trials for different clinical populations such as breast 




Matthews et al. found significant increases in physical 
activity levels among breast cancer survivors completing 
a similar home-based exercise program as this one.
17
 
Similar to this study, Matthews and colleagues focused 
on increasing activity levels of a previously sedentary 
clinical population using a similar telephone-based 
coaching and behavior modification technique. The 
intervention resulted in a 12 MET-h/week increase 
among breast cancer survivors and 76% of the women in 
the intervention were active 5 days a week or more 
during the final 4 weeks of the intervention. A major 
difference between our study and the one by Matthews et 
al was the length of the intervention (12 weeks compared 
to 36). However when measured at 18 weeks, our 
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population did not show any increases in daily physical 
activity. Another possible explanation for the conflicting 
results could be the population itself. PLWHA are known 
to have inconsistent periods of good and bad health. 
Depression and anxiety are also very common when 
faced with a chronic condition like HIV making it that 
much harder to be active consistently.
12,37
  In the study by 
Matthews and colleagues they recruited survivors of 
breast cancer. The women in that investigation were 
possibly more focused on improving their health and 
quality of life since they had just overcome a life 




Analysis of Increased Physical Activity 
In a secondary data analysis we separated the participants 
into one of two groups at both the 18 week and 36 week 
follow-ups: 1) those who increased daily moderate 
intensity physical activity minutes by more than 10% 
compared to baseline, and 2) those who accumulated 
10% or less of moderate intensity physical activity 
compared to their baseline measurement. This was done 
in an effort to test the effects of increased activity 
particularly on markers of cardio-metabolic risk. What 
we found were significant changes in two variables, both 
of which are known risk factors for CVD. More 
specifically, those who increased daily physical activity 
saw a decrease in waist circumference and systolic blood 
pressure. Although not significant, some individuals 
experienced improved lipid profiles, such as increased 
HDL cholesterol and decreased LDL cholesterol.  These 
findings are similar to what would be expected among 
healthy individuals and would further indicate the 
importance to identify simple and cost-effective 
interventions that successfully increase physical activity 
among PLWHA.  
 
As presented in Table 3.1, there was a slight downward 
trend at 18 weeks in most of the psychological variables, 
including physical functioning, physical and emotional 
health, energy/fatigue, mental and social health, pain, and 
general health. At 36 weeks, a stronger downward trend 
was observed for pain and emotional health; however 
physical functioning, mental and social health, 
energy/fatigue, and general health did not show 
significant change. None of the changes observed were 
significant after controlling for all potential confounders. 
Various factors could have contributed to this lack of 
significance. For example the length of time between 
questionnaires and characteristics of the population are 
possible reasons. The participants completed the profile 
of mood states questionnaire a total of 3 times: baseline, 
18 weeks, and 36 weeks. To observe a true relationship, 
this should be completed multiple times throughout the 
week and studied using an average of those results. Other 
researchers have observed a trend between pain and 
mood with exercise.
37,38
 Neidig et al saw a decrease in 
depressive symptoms in HIV infected individuals after a 
12 week exercise intervention using the CES-D and 
POMS depression subscale.
37
 This group is known to 
have multiple comorbidities, side effects to medications, 
socioeconomic barriers, and psychosocial concerns.   
 
A possible strategy to improve studies similar to this is to 
incorporate a group based social interaction each week 
similar to that of a support group. It also would be ideal 
to include a type of “buddy system” or asking 
participants to recruit a partner to exercise with them. 
Studies have consistently shown the importance of social 
support among physical activity and the social interaction 
will often increase the chances of success when someone 
is beginning a new workout program.
39
 Many of the 
participants of this trial actually asked if such a system 
was in place. Since this was a single-person study design, 
it was explained to them that being paired with a partner 
was not part of the study protocol, but it was encouraged 
that they find a friend or loved one who might be able to 
exercise with them.  
 
One of the most significant findings of this study was 
further evidence showing a strong inverse relationship 
between waist circumference and increased physical 
activity. In a previous article from this study, we showed 
moderate intensity physical activity to be a significant 
predictor for waist circumference.
7
 Although the 
intervention itself was not successful in increasing 
physical activity, when the sample was divided into 
groups according to changes in physical activity, the data 
showed that regardless of group assignment those who 
significantly increased their daily physical activity 
significantly decreased their waist circumference at the 
18 week time point.  
 
Strengths and limitations of the current study should be 
taken into careful consideration and may explain some of 
our findings, or lack thereof. The strengths included 
recruiting an HIV population with almost equal numbers 
of males and females, which allowed for comparing 
possible gender differences of significant findings. It 
should also be noted that this clinical trial incorporated a 
randomized design of physically inactive HIV+ patients 
and an analysis plan that utilized intent-to-treat 
principles. The lack of significance of increased physical 
activity for those randomized to the intervention group 
would indicate that future studies should take a different 
approach to increase daily physical activity of similar 
populations. It should be noted that there are multiple 
barriers PLWHA face that need to be taken into 
consideration when developing future interventions 
including socioeconomic, personal, social, and 
environmental factors. Mgbere et al found numerous 
barriers that can adversely affect care access: negative 
perceptions of the health care system, longer wait time 
for appointments, lack of flexibility in clinic hours, unmet 
needs for child care, lack of access to a provider with 
expertise in treating HIV, strained patient–provider 
relationship, patient concerns about privacy, mandatory 
insurance coverage, and multiple funding sources with 
variable eligibility criteria. On the individual level, they 
noted multiple barriers which prevent or decrease 
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PLWHA from utilizing health care including mental 
health issues and drug addictions, HIV stigma, limited 
social support, unstable housing and transportation, 
incarceration, undocumented immigrant status, and 
avoidance and denial of HIV status.
40
 When separated 
into groups according to change in physical activity, it 
was observed that health benefits could be obtained 
within 18 weeks for this specific population. In addition 
to a randomized design, this study also incorporated 
objective measures of physical activity and sedentary 
behavior using the Sensewear® armband. 
Several limitations should be noted as well. This 
population was comprised primarily of African-
Americans from lower socio-economic status and 
majority reported a yearly income less than $30,000. This 
does not allow us to generalize the findings across other 
races or individuals living with HIV with a higher yearly 
income who may have access to other means for physical 
activity such as gyms or home exercise equipment. 
Although this investigation examined numerous 
confounding variables, the lack of unmeasured covariates 
cannot be ruled out. Some of these include weekly, or 
even daily, health status and dietary intake. Another 
covariate could potentially be chronic pain and/or 
peripheral neuropathy which is very common among 
PLWHA and known to limit activity levels.
41
 Other 
limitations include the lack of dietary data and exercise 
log to determine weekly adherence.
 
CONCLUSION 
Increasing the daily amount of routine physical activity 
has been shown to lead to significant health 
improvements in multiple populations.
4,7,15,23
 With 
increases in life expectancy due to the advances in 
treating HIV, daily physical activity is an important step 
in helping PLWHA self-manage the detrimental side 
effects often associated with pharmacological treatment, 
as well reduce the risk of developing chronic comorbid 
conditions such as CVD and diabetes. Since the 
antiretroviral regimen has because a necessity to halt viral 
replication it is critical that we discover better ways to 
improve the long term health for those living with HIV. 
Daily activity has shown promising results in other 
clinical populations, but with limited evidence among the 
HIV population. Additional research is needed to not 
only test the hypothesis that long term changes in 
physical activity behaviors would improve quality of life 
by helping self-manage the illness, but also to discover 
more cost-effective and practical ways to achieve this 
lifestyle change. With increased rates of new infections 
occurring in more rural areas and those of lower socio-
economic status it is imperative that community-based 
programs tailored to these individuals are developed. 
Such programs will not be possible without first 
increasing efforts of bridging clinical-community 
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